The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics

Консенсусное заявление Международной научной ассоциации пробиотиков и пребиотиков (ISAPP) об определении и сфере применения постбиотиков
Colin Hill, María Carmen Collado, Raanan Shamir, Mary Ellen Sanders, Seppo Salminen, Gabriel Vinderola, Hania Szajewska, Eamonn M.M. Quigley, Sarah Lebeer, Akihito Endo, Jonathan R. Swann
2021-05-04

health benefitsinanimate microorganismsmicrobial cell componentspostbioticsregulatory clarity
Abstract In 2019, the International Scientific Association for Probiotics and Prebiotics (ISAPP) convened a panel of experts specializing in nutrition, microbial physiology, gastroenterology, paediatrics, food science and microbiology to review the definition and scope of postbiotics. The term ‘postbiotics’ is increasingly found in the scientific literature and on commercial products, yet is inconsistently used and lacks a clear definition. The purpose of this panel was to consider the scientific, commercial and regulatory parameters encompassing this emerging term, propose a useful definition and thereby establish a foundation for future developments. The panel defined a postbiotic as a “preparation of inanimate microorganisms and/or their components that confers a health benefit on the host”. Effective postbiotics must contain inactivated microbial cells or cell components, with or without metabolites, that contribute to observed health benefits. The panel also discussed existing evidence of health-promoting effects of postbiotics, potential mechanisms of action, levels of evidence required to meet the stated definition, safety and implications for stakeholders. The panel determined that a definition of postbiotics is useful so that scientists, clinical triallists, industry, regulators and consumers have common ground for future activity in this area. A generally accepted definition will hopefully lead to regulatory clarity and promote innovation and the development of new postbiotic products.
1
A standardized definition is intended to provide common ground for researchers, clinicians, industry, regulators, and consumers.
2
An ISAPP expert panel established a consensus definition of postbiotics as preparations of inanimate microorganisms and/or their components that confer a health benefit on the host.
3
Effective postbiotics must contain inactivated microbial cells or cellular components, with or without metabolites, that contribute to the observed health benefits.
4
The consensus addresses scientific, commercial, and regulatory considerations, including mechanisms, evidence requirements, safety, and stakeholder implications.
5
The panel concluded that definitional clarity could support regulatory clarity, innovation, and development of new postbiotic products.

Postbiotics (preparations of inanimate microorganisms and/or their components)

the definition, scope, health benefits, mechanisms of action, evidence requirements, safety, and regulatory and commercial implications of postbiotics

Publication Details
Publication Date
2021-05-04
Journal
Publisher
ISSN
Cited by
2368
Access Type
Author Information
Authors
Colin Hill
María Carmen Collado
Raanan Shamir
Mary Ellen Sanders
Seppo Salminen
Gabriel Vinderola
Hania Szajewska
Eamonn M.M. Quigley
Sarah Lebeer
Akihito Endo
Jonathan R. Swann
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat
Make a presentation
100%